EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation
- PMID: 20388738
- DOI: 10.1136/ard.2009.116624
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation
Erratum in
- Ann Rheum Dis. 2011 Feb;70(2):397. Paut, Isabelle Kone [corrected to Kone-Paut, Isabella]
Abstract
Objectives: To report methodology and overall clinical, laboratory and radiographic characteristics for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) classification criteria.
Methods: The preliminary Vienna 2005 consensus conference, which proposed preliminary criteria for paediatric vasculitides, was followed by a EULAR/PRINTO/PRES - supported validation project divided into three main steps. Step 1: retrospective/prospective web-data collection for HSP, c-PAN, c-WG and c-TA, with age at diagnosis <or=18 years. Step 2: blinded classification by consensus panel of a subgroup of 280 cases (128 difficult cases, 152 randomly selected) enabling expert diagnostic verification. Step 3: Ankara 2008 Consensus Conference and statistical evaluation (sensitivity, specificity, area under the curve, kappa-agreement) using as 'gold standard' the final consensus classification or original treating physician diagnosis.
Results: A total of 1183/1398 (85%) samples collected were available for analysis: 827 HSP, 150 c-PAN, 60 c-WG, 87 c-TA and 59 c-other. Prevalence, signs/symptoms, laboratory, biopsy and imaging reports were consistent with the clinical picture of the four c-vasculitides. A representative subgroup of 280 patients was blinded to the treating physician diagnosis and classified by a consensus panel, with a kappa-agreement of 0.96 for HSP (95% CI 0.84 to 1), 0.88 for c-WG (95% CI 0.76 to 0.99), 0.84 for c-TA (95% CI 0.73 to 0.96) and 0.73 for c-PAN (95% CI 0.62 to 0.84), with an overall kappa of 0.79 (95% CI 0.73 to 0.84).
Conclusion: EULAR/PRINTO/PRES propose validated classification criteria for HSP, c-PAN, c-WG and c-TA, with substantial/almost perfect agreement with the final consensus classification or original treating physician diagnosis.
Similar articles
-
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.Ann Rheum Dis. 2010 May;69(5):798-806. doi: 10.1136/ard.2009.116657. Ann Rheum Dis. 2010. PMID: 20413568
-
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.Ann Rheum Dis. 2006 Jul;65(7):936-41. doi: 10.1136/ard.2005.046300. Epub 2005 Dec 1. Ann Rheum Dis. 2006. PMID: 16322081 Free PMC article.
-
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children.Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI122-SI128. doi: 10.1093/rheumatology/kead693. Rheumatology (Oxford). 2024. PMID: 38135503
-
Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides.Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S162-8. Epub 2012 May 14. Clin Exp Rheumatol. 2012. PMID: 22640658
-
A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.Ann Rheum Dis. 2000 Jun;59(6):478-82. doi: 10.1136/ard.59.6.478. Ann Rheum Dis. 2000. PMID: 10834866 Free PMC article.
Cited by
-
Involvement of M1-Activated Macrophages and Perforin/Granulysin Expressing Lymphocytes in IgA Vasculitis Nephritis.Int J Mol Sci. 2024 Feb 13;25(4):2253. doi: 10.3390/ijms25042253. Int J Mol Sci. 2024. PMID: 38396930 Free PMC article.
-
Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report.Vaccines (Basel). 2021 Sep 25;9(10):1078. doi: 10.3390/vaccines9101078. Vaccines (Basel). 2021. PMID: 34696186 Free PMC article.
-
A predictive model to explore risk factors for Henoch-Schönlein purpura nephritis in children: a retrospective cross-sectional study.Front Public Health. 2025 Mar 19;13:1507408. doi: 10.3389/fpubh.2025.1507408. eCollection 2025. Front Public Health. 2025. PMID: 40177080 Free PMC article.
-
Pediatric vasculitis.Curr Rheumatol Rep. 2012 Apr;14(2):121-9. doi: 10.1007/s11926-011-0232-4. Curr Rheumatol Rep. 2012. PMID: 22231274 Review.
-
Polyarteritis nodosa: decreasing incidence in Poland.Arch Med Sci. 2019 Sep;15(5):1308-1312. doi: 10.5114/aoms.2017.68407. Epub 2017 Oct 5. Arch Med Sci. 2019. PMID: 31572478 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical